Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

GLI1-Altered Soft Tissue Tumor — Statistics · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Connective and Soft Tissue Neoplasm
Soft Tissue Neoplasm
Intermediate Soft Tissue Neoplasm
GLI1-Altered Soft Tissue Tumor

Molecular Subtype

GLI1-Altered Soft Tissue Tumor

CI-CAN-00002777GAESTTExplore in graph →

Non-malignant5 evidence items

NCIt: C202896
DOID: 0080896

Overview
Statistics
Survival
Genomics
Variants & evidence5
Drugs
Trials
Research
Rankings
Sources & provenance

Epidemiology

Incidence, mortality and prevalence

Data not yet available

No epidemiology observation is attached to this entity. Population statistics come from registries (SEER, CDC WONDER) and the IARC Global Cancer Observatory; IARC data stays under license review and SEER awaits credentials, so no burden figure is displayed. Statistics are attached per geography, year and sex — never invented or extrapolated.

What CancerIndex knows

Taxonomy and codes
Source registry and license status